You are here

  • Home
  • Archive
  • Volume 11, Issue 1
  • Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the UK

Citation Tools

Article menu
Epidemiology/Health services research
Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the UK

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Gonzalez Perez A, Vizcaya D, Sáez ME, et al
Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the UK
BMJ Open Diabetes Research and Care 2023;11:e003072. doi: 10.1136/bmjdrc-2022-003072